- Home
- OMH vs LVTX Comparison
OMH vs LVTX Comparison
Compare OMH & LVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OMH
- LVTX
- Stock Information
- Founded
- OMH 2015
- LVTX 2016
- Country
- OMH Singapore
- LVTX Netherlands
- Employees
- OMH 108
- LVTX N/A
- Industry
- OMH Real Estate
- LVTX Biotechnology: Pharmaceutical Preparations
- Sector
- OMH Finance
- LVTX Health Care
- Exchange
- OMH Nasdaq
- LVTX Nasdaq
- Market Cap
- OMH 35.8M
- LVTX 33.9M
- IPO Year
- OMH 2023
- LVTX 2021
- Fundamental
- Price
- OMH $1.47
- LVTX $1.37
- Analyst Decision
- OMH Hold
- LVTX Hold
- Analyst Count
- OMH 1
- LVTX 3
- Target Price
- OMH N/A
- LVTX $1.75
- AVG Volume (30 Days)
- OMH 179.3K
- LVTX 10.4K
- Earning Date
- OMH 07-18-2025
- LVTX 08-19-2025
- Dividend Yield
- OMH N/A
- LVTX N/A
- EPS Growth
- OMH N/A
- LVTX N/A
- EPS
- OMH N/A
- LVTX N/A
- Revenue
- OMH $7,976,578.00
- LVTX $4,990,000.00
- Revenue This Year
- OMH $28.40
- LVTX N/A
- Revenue Next Year
- OMH $23.07
- LVTX N/A
- P/E Ratio
- OMH N/A
- LVTX N/A
- Revenue Growth
- OMH 117.53
- LVTX N/A
- 52 Week Low
- OMH $0.59
- LVTX $0.85
- 52 Week High
- OMH $6.20
- LVTX $2.39
- Technical
- Relative Strength Index (RSI)
- OMH 45.64
- LVTX 60.82
- Support Level
- OMH $1.32
- LVTX $1.27
- Resistance Level
- OMH $1.60
- LVTX $1.40
- Average True Range (ATR)
- OMH 0.10
- LVTX 0.05
- MACD
- OMH 0.03
- LVTX 0.00
- Stochastic Oscillator
- OMH 53.07
- LVTX 73.08
About OMH Ohmyhome Limited
Ohmyhome Ltd is a data and technology-driven property technology company based in Singapore. Through its subsidiaries, it operates a one-stop-shop property platform that provides end-to-end property solutions and services for its customers, which comprises brokerage services and emerging and other services, such as home renovation and furnishing services, listing and research, mortgage referral, legal services, and insurance referral services. The company derives its revenues from two sources: revenue from brokerage services, property management services, and revenue from emerging and other services.
About LVTX LAVA Therapeutics N.V.
LAVA Therapeutics NV isa clinical stage immuno-oncology company. It is focused on transforming cancer treatment by developing a platform to selectively induce bispecific antibody utilizing the Gammabody platform for an undisclosed tumor associated antigen for the treatment of cancer. Company's pipeline include's products such as LAVA-1266, LAVA-1427, LAVA-1433, LAVA-1207, PF08046052, JNJ89853413.